Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report

Overview of attention for article published in Diabetes Care, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news: 1 news outlet
patent: 8 patents

guideline: 3 clinical guideline sources

Readers on

mendeley: 117 Mendeley

So far, Altmetric has seen 3 news stories from 1 outlets.

Tzield : Newest Type 1 Diabetes Drug | Drug Discovery And Development

LabRoots, 03 Feb 2023

Type 1 Diabetes (T1D) is a autoimmune genetic disease that results in a persons pancreas not making enough insulin to sustain…

Tzield : Newest Type 1 Diabetes Drug | Drug Discovery And Development

LabRoots, 03 Feb 2023

Type 1 Diabetes (T1D) is a autoimmune genetic disease that results in a persons pancreas not making enough insulin to sustain…

Tzield : Newest Type 1 Diabetes Drug | Drug Discovery And Development

LabRoots, 03 Feb 2023

Type 1 Diabetes (T1D) is a autoimmune genetic disease that results in a persons pancreas not making enough insulin to sustain…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.